In this Update Main Article Introduction FDA-Approved Medications Experimental Medications New Directions in MS Research Closing Notes Approved Disease-Modifying Therapies for MS (PDF) References Experimental Medications: Monoclonal Antibodies Company: GeNeuro SA […]
Read News ArticleSearch Results for:
Ublituximab (also known as TG-1101)
In this Update Main Article Introduction FDA-Approved Medications Experimental Medications New Directions in MS Research Closing Notes Approved Disease-Modifying Therapies for MS (PDF) References Experimental Medications: Monoclonal Antibodies Company: TG Therapeutics […]
Read News ArticleOpicinumab
In this Update Main Article Introduction FDA-Approved Medications Experimental Medications New Directions in MS Research Closing Notes Approved Disease-Modifying Therapies for MS (PDF) References Experimental Medications: Monoclonal Antibodies Company: Biogen 750 […]
Read News ArticleOfatumumab (also known as Arzerra®)
In this Update Main Article Introduction FDA-Approved Medications Experimental Medications New Directions in MS Research Closing Notes Approved Disease-Modifying Therapies for MS (PDF) References Experimental Medications: Monoclonal Antibodies Company: Novartis Given […]
Read News ArticleRituxan® (rituximab)
In this Update Main Article Introduction FDA-Approved Medications Experimental Medications New Directions in MS Research Closing Notes Approved Disease-Modifying Therapies for MS (PDF) References Experimental Medications: Monoclonal Antibodies Company: Genentech/Roche Given […]
Read News ArticleBetaseron® (interferon beta-1b)
In this Update Main Article Introduction FDA-Approved Medications Experimental Medications New Directions in MS Research Closing Notes Approved Disease-Modifying Therapies for MS (PDF) References FDA-Approved Medications: New Data on Previously Approved […]
Read News ArticleCopaxone® (glatiramer acetate)
In this Update Main Article Introduction FDA-Approved Medications Experimental Medications New Directions in MS Research Closing Notes Approved Disease-Modifying Therapies for MS (PDF) References FDA-Approved Medications: New Data on Previously Approved […]
Read News ArticleAubagio® (teriflunomide)
In this Update Main Article Introduction FDA-Approved Medications Experimental Medications New Directions in MS Research Closing Notes Approved Disease-Modifying Therapies for MS (PDF) References FDA-Approved Medications: New Data on Previously Approved […]
Read News ArticlePlegridy® (peginterferon beta-1a)
In this Update Main Article Introduction FDA-Approved Medications Experimental Medications New Directions in MS Research Closing Notes Approved Disease-Modifying Therapies for MS (PDF) References FDA-Approved Medications: New Data on Previously Approved […]
Read News ArticleLemtrada® (alemtuzumab)
In this Update Main Article Introduction FDA-Approved Medications Experimental Medications New Directions in MS Research Closing Notes Approved Disease-Modifying Therapies for MS (PDF) References FDA-Approved Medications: New Data on Previously Approved […]
Read News Article